Showing results (3421-3430 of 11,196) with videos related to
Sort By:
Pageof 1,120
Journal of Neurology|September 19, 2000
Projections from basal ganglia to tegmentum: a subcortical route for explaining the pathophysiology of Parkinson's disease signs?P J Delwaide, J L Pepin, V De Pasqua, et al.Journal of Neurology|September 19, 2000
The two faces of Alzheimer's diseaseW A van Gool, P EikelenboomJournal of Neurology|September 19, 2000
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosisL Vanopdenbosch, B Dubois, M B D'Hooghe, et al.Journal of Neurology|March 4, 2000
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled studyM C Walter, H Lochmüller, M Toepfer, et al.Journal of Neurology|March 4, 2000
The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseasesM Rovaris, M Inglese, B Viti, et al.Journal of Neurology|March 4, 2000
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurementP D Molyneux, D H Miller, M Filippi, et al.Journal of Neurology|April 6, 2000
Oral pulsed high-dose dexamethasone for myositisM F van der Meulen, J E Hoogendijk, J H Wokke, et al.Journal of Neurology|April 29, 2000
Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 alleleT Fukazawa, S Kikuchi, H Sasaki, et al.Journal of Neurology|April 29, 2000
Antisaccades and remembered saccades in mild traumatic brain injuryL Crevits, M C Hanse, P Tummers, et al.Journal of Neurology|April 29, 2000
Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebosA J de Craen, J G Tijssen, J de Gans, et al.Pageof 1,120